Category: Disease Discoveries
-
AI-Enhanced Approach Offers New Hope for Earlier Autism Diagnoses
A Northwestern Medicine scientist and collaborators have used an AI-enhanced precision medicine approach to combine multiple views of human brain development as they seek to provide a roadmap for what causes subtypes of autism spectrum disorder.
-
Analyzing Plasma Can Classify Brain Tumors
Measuring epigenetic signatures in blood plasma could help classify brain tumors, according to a study published in Nature Medicine.
-
Protein May Improve Immunotherapy for Medulloblastoma
A specific cell signaling protein may be used to enhance the sensitivity of medulloblastoma tumors to immunotherapy, potentially improving quality of life for patients with the malignant pediatric brain cancer.
-
New Inhibitor Starves HIV
An emerging cancer treatment also helps prevent cells from turning into viral factories by interfering with HIV infection processes inside the cell, according to a recent study.
-
New Therapy Extends Breast Cancer Survival Rate, Prevents Reoccurrence
A new immunotherapy developed by investigators at Northwestern University dramatically extends the survival time of mice with triple negative breast cancer, one of the most aggressive and difficult-to-treat forms of breast cancer.
-
Chimeric Toxin Slows Cancer Growth
A novel compound using diphtheria toxin to attack a signaling pathway implicated in as many as 50 percent of cancers slowed tumor growth, according to a recent study.
-
Strategies for Evaluating Breast Cancer with Machine Learning
Machine-learning technology could help pathologists more accurately assess how a patient’s immune system is responding to breast cancer, according to a recent series of reports authored in part by Feinberg faculty.
-
New Insights into Left Ventricular Cardiomyopathy
Genetic mutations in desmoplakin cause left ventricular cardiomyopathy, rather than right ventricular cardiomyopathy as previously believed, according to a recent study.
-
Antibody Testing Project Receives NSF RAPID Grant
Northwestern investigators have received a $200,000 grant from the National Science Foundation to examine the determinants of SARS-CoV-2 exposure with a minimally invasive approach to community-based serological testing.
-
New Mechanism for Oncogenic Gene Splicing
Northwestern Medicine scientists have discovered an alternate mechanism for aberrant gene splicing that contributes to T-cell lymphoblastic leukemia, according to a recent study.
